Smith Cynthia

Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
SPRO	Spero Therapeutics, Inc.	$0	$0	$0	85,000	Jun 23
AGIO	Agios Pharmaceuticals, INC.	$0	$0	$0	15,230	Jun 18
AKBA	Akebia Therapeutics, Inc.	$0	$0	$0	196,633	Jun 17
TARA	Protara Therapeutics, Inc.	$0	$0	$0	—	Jun 15
TVRD	Tvardi Therapeutics, Inc.	$0	$0	$0	—	Jun 9

SPRO

Spero Therapeutics, Inc.

Bought

Sold

Held

85,000

AGIO

Agios Pharmaceuticals, INC.

Bought

Sold

Held

15,230

AKBA

Akebia Therapeutics, Inc.

Bought

Sold

Held

196,633

TARA

Protara Therapeutics, Inc.

Bought

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 11 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 21 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Jun 23	SPRO	Spero Therapeutics, Inc.	AGRANT◆	20,000	—	—	—	Open the original filing on SEC.gov
Jun 23	SPRO	Spero Therapeutics, Inc.	AGRANT	10,000	—	—	+13.3%